Track how lactate levels change in septic shock
Part of Infections clinical trials.
This study measures how quickly a blood marker called lactate rises or falls in people with septic shock. It may help doctors understand which patterns are linked to recovery and guide better treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sepsis
- You are older than 17 years
- You have an arterial line (a catheter in an artery) placed
- Your lactate level was above 2 mmol/L at some point before joining
- You do not have a known mitochondrial (energy-making) defect
- You do not have a degenerative muscle disease
- You do not have terminal liver failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures fluid levels outside your cells to better understand and manage sepsis. It may help doctors give the right amount of fluids during treatment.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.
This study checks if a simple blood test (the ratio of urea to creatinine) can help doctors understand changes in your metabolism during septic shock. It compares this test to a more detailed measurement of how your body uses energy. This might help guide your treatment without extra invasive procedures.
This study looks at how the body uses energy (metabolism) in people with septic shock. It collects information from standard monitoring during a fluid challenge (a small IV fluid test) to find patterns that might help doctors better understand and treat septic shock.
This trial tests a wearable sweat sensor to monitor lactate levels in critically ill patients. It may help doctors track your condition more easily and comfortably.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.